(Q59120756)
Statements
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group (English)
F Martin
M Poleski
C Dallaire
R Rossman
F Saibil
L Lariviere
L R Sutherland